Evidence map›Paper›PMID 34120897›Full record

ArticleJournal of Alzheimer's disease : JAD2021

Global Perspectives on Brief Cognitive Assessments for Dementia Diagnosis.

Elena Tsoy, Alissa Bernstein Sideman, Stefanie D Piña Escudero, Maritza Pintado-Caipa, Suchanan Kanjanapong, Tala Al-Rousan, Lingani Mbakile-Mahlanza, Maira Okada de Oliveira, Myriam De la Cruz Puebla, Stelios Zygouris and 6 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. The landscape of dementia research, diagnosis, treatment, and care in Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  2. Article
  3. Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Elena TsoyDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Alissa Bernstein SidemanDepartment of Humanities and Social Sciences, University of California, San Francisco, San Francisco, CA, USA.
Stefanie D Piña EscuderoGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Maritza Pintado-CaipaGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Suchanan KanjanapongDivision of Geriatrics, Department of Preventive Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Tala Al-RousanGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Lingani Mbakile-MahlanzaGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Maira Okada de OliveiraGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Myriam De la Cruz PueblaGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Stelios ZygourisGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Aya Ashour MohamedGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Hany IbrahimGlobal Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA.
Collette A GoodeDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Bruce L MillerDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Victor ValcourDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Katherine L PossinDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.

Funding

The UCSF Brain Health Assessment for the Detection of Cognitive Impairment Among Diverse Populations in Primary CareUG3NS105557 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI POSSIN, KATHERINE LAUREL · 2017 to 2018
$2.4M
Hypertension Self-management in Refugees Living in San DiegoK23HL148530 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AL-ROUSAN, TALA · 2020 to 2024
$882k
Mapping the Dynamics of Caregiver Burden in Alzheimer's DiseaseK01AG059840 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SIDEMAN, ALISSA BERNSTEIN · 2020 to 2024
$652k
NHLBI NIH HHS K23 HL148530NIA NIH HHS K01 AG059840NINDS NIH HHS UG3 NS105557
6 · The paper itself

Abstract

backgroundTimely diagnosis of dementia is a global healthcare priority, particularly in low to middle income countries where rapid increases in older adult populations are expected.

objectiveTo investigate global perspectives on the role of brief cognitive assessments (BCAs) in dementia diagnosis, strengths and limitations of existing measures, and future directions and needs.

methodsThis is a qualitative study of 18 dementia experts from different areas of the world. Participants were selected using purposeful sampling based on the following criteria: 1) practicing in countries with projected growth of older adult population of over 100%by 2050; 2) expertise in dementia diagnosis and treatment; 3) involvement in clinical practice and training; and 4) recognition as a national dementia expert based on leadership positions within healthcare system, research, and/or policy work. Participants were individually interviewed in their language of choice over secure videoconference sessions. Interviews were analyzed by a multidisciplinary team using theme identification approach.

resultsFour domains with subthemes emerged illustrating participants' perspectives: 1) strengths of BCAs; 2) limitations of BCAs; 3) needs related to the use of BCAs; and 4) characteristics of an ideal BCA. While most experts agreed that BCAs were important and useful for dementia diagnosis, the themes emphasized the need for development and validation of novel measures that are sensitive, psychometrically sound, and culturally appropriate.

conclusionBCAs are important for guiding diagnosis and care for dementia patients. Findings provide a roadmap for novel BCA development to assist in diagnostic decision making for clinicians serving a rapidly growing and diverse dementia population.

Indexed as

Qualitative ResearchCognitive DysfunctionDementiaGlobal HealthHumansPhysiciansSurveys and QuestionnairesWechsler Memory ScaleAlzheimer’s diseasecultural diversitydementiamental status and dementia testsmild cognitive impairment

Identifiers

PMID34120897
PMCPMC9450569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.